Lyra Therapeutics Stock Probability of Future Stock Price Finishing Over 195.5
| LYRA Stock | USD 9.31 0.41 4.61% |
Lyra Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Lyra Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Lyra Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Lyra Therapeutics is way too risky over 90 days horizon | |
| Lyra Therapeutics appears to be risky and price may revert if volatility continues | |
| Lyra Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 1.53 M. Net Loss for the year was (93.44 M) with loss before overhead, payroll, taxes, and interest of (29.22 M). | |
| Lyra Therapeutics currently holds about 120.67 M in cash with (70.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.79. |
Lyra Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Lyra Stock often depends not only on the future outlook of the current and potential Lyra Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Lyra Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 65.1 M | |
| Cash And Short Term Investments | 40.6 M |
Lyra Therapeutics Technical Analysis
Lyra Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Lyra Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Lyra Therapeutics. In general, you should focus on analyzing Lyra Stock price patterns and their correlations with different microeconomic environments and drivers.
Lyra Therapeutics Predictive Forecast Models
Lyra Therapeutics' time-series forecasting models is one of many Lyra Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Lyra Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Lyra Therapeutics
Checking the ongoing alerts about Lyra Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Lyra Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Lyra Therapeutics is way too risky over 90 days horizon | |
| Lyra Therapeutics appears to be risky and price may revert if volatility continues | |
| Lyra Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 1.53 M. Net Loss for the year was (93.44 M) with loss before overhead, payroll, taxes, and interest of (29.22 M). | |
| Lyra Therapeutics currently holds about 120.67 M in cash with (70.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.79. |
Check out Lyra Therapeutics Backtesting, Lyra Therapeutics Valuation, Lyra Therapeutics Correlation, Lyra Therapeutics Hype Analysis, Lyra Therapeutics Volatility, Lyra Therapeutics History as well as Lyra Therapeutics Performance. For information on how to trade Lyra Stock refer to our How to Trade Lyra Stock guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Medical Equipment space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lyra Therapeutics. If investors know Lyra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lyra Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Lyra Therapeutics is measured differently than its book value, which is the value of Lyra that is recorded on the company's balance sheet. Investors also form their own opinion of Lyra Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Lyra Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lyra Therapeutics' market value can be influenced by many factors that don't directly affect Lyra Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lyra Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Lyra Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lyra Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.